Under the initiative of the Ministry of Science and Technology (MoST) of Taiwan, Taiwan Tech Arena (TTA) led 12 startups that have some of the best minds in medical technology to Boston. By showcasing their innovative tech solutions during the MedTech Conference 2019 (23-25, Sept.) and TTA Demo Day (27, Sept.), those startups had gained 125 million USD equivalent business opportunities.
At the opening ceremony of TTA Pavilion, Director General Hsu from Taipei Economic and Cultural Office in Boston first welcomed all startup teams to Boston, and indicated that Boston is an important base for the global medical technology and life science industry. There are 16 of the world's top 20 pharmaceutical companies established here, including Novartis's laboratory, the world's leading pharmaceutical company, and GE with a large scale of bio-business also have moved to Boston.
“The AdvaMed is
the most important association in the global medical technology industry, with highly
professional associated companies, new startups and multinational corporations.
Since Taiwan’s medical technology industry technology is quite standard, he believed
that it can expand the global medical market and create more business
opportunities in this Conference.” Said Ralph F. Ives, the Executive Vice
President of AdvaMed (host of the MedTech Conference).
The MoST also mentioned
that it has initiated TTA to assist domestic talents in connecting with the
global startup ecosystems and has established a mutually beneficial partnership
to create opportunities for Taiwan’s entrepreneurs to enter the overseas markets.
The MoST expects to engage with international resources and investors via participating
in important global events.
TTA Startups Drew
Attentions from the World
Conference is hosted by AdvaMed, the event involves 80 international
medical-related companies and 400 key industry members to create important
influence of MedTech in the global market. TTA’s 12 medical startups have drawn
attentions in the exhibition.
-Heroic-Faith Medical Science Co., Ltd. demonstrated its latest artificial intelligence combined with respiratory monitoring during the show, and was approved by the US Food and Drug Administration FDA, the American College of Anesthesiology, the American Dental Association, and the US Military Medical Unit. Respiratory monitoring, voice recognition and other functions obtained its clinical trial and business cooperation.
-APrevent Medical Inc.'s postoperative adjustable throat implant obtained the global pathway cooperation with Japanese medical materials.
-FaceHeart Inc.'s AI face recognition detection
Heartbeat technology collaborated with HP's photography identification and
Qiaoshan Health Equipment's cloud-based smart system.
-Summed Taiwan Inc.'s medical catheter and wound
patch platform reached an early stage cooperation opportunity with
international giants Terumo, Academic Institutions University of Pittsburgh and
University of Massachusetts during the exhibition.
Taipei Economic and
Cultural Office in Boston First Held TTA Demo Day to Introduce Boston’s
Med-Tech Investment Ecosystem
In order to introduce med-tech investment ecosystem in Boston, Taipei
Economic and Cultural Office in Boston held TTA Demo Day on 27th. TTA’s
startups showcased their innovative med-tech to representatives from MPM
Capital Founder, Flare Capital Partners, Alira Health, Leading Business
Ventures, and Medtronic. In addition, there was also a panel discussion on “Boston’s
Innovation Ecosystem and Strategies for International Startups to Integrate” held
during the event; the Panel discussion had attracted more than 100 participants.
TTA, Empowering Tech
TTA not only aims to connect Taiwanese startups with global startup
ecosystems, but also promotes development of AI, software, and semiconductor in
med-tech. Through participating in global events, TTA’s startups can draw
attentions from investors and will have more chance to collaborate with global
Department of Academia-Industrial
Collaboration and Science Park Affairs,
Ministry of Science and Technology (MOST)
Tel : 02-2737-7981